{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:32:05Z","timestamp":1771263125381,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.beem.2010.10.017","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T16:25:37Z","timestamp":1308500737000},"page":"459-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Molecular mechanisms for insulin resistance in treated HIV-infection"],"prefix":"10.1016","volume":"25","author":[{"given":"Paul W.","family":"Hruz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2010.10.017_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/QAD.0b013e32832bd7af","article-title":"HIV infection and the risk of diabetes mellitus","volume":"23","author":"Butt","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.10.017_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2010.10.017_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","article-title":"Adipose tissue as an endocrine organ","volume":"316","author":"Galic","year":"2010","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.beem.2010.10.017_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/pgmj.2008.078014","article-title":"The metabolic syndrome: common origins of a multifactorial disorder","volume":"85","author":"Bruce","year":"2009","journal-title":"Postgraduate Medical Journal"},{"key":"10.1016\/j.beem.2010.10.017_bib5","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1210\/jc.2002-020794","article-title":"Clinical review 153: lipodystrophy in human immunodeficiency virus-infected patients","volume":"87","author":"Chen","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.017_bib6","doi-asserted-by":"crossref","first-page":"41325","DOI":"10.1074\/jbc.M006474200","article-title":"Suppression of preadipocyte differentiation and Promotion of adipocyte Death by HIV protease inhibitors","volume":"275","author":"Dowell","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2010.10.017_bib7","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/oby.2006.114","article-title":"HIV protease inhibitor-specific alterations in human adipocyte differentiation and metabolism[ast]","volume":"14","author":"Kim","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.beem.2010.10.017_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-3542(00)00102-9","article-title":"HIV protease inhibitors block adipogenesis and increase lipolysis in vitro","volume":"47","author":"Lenhard","year":"2000","journal-title":"Antiviral Research"},{"key":"10.1016\/j.beem.2010.10.017_bib9","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1210\/jcem.84.11.6234","article-title":"Inhibition of adipocyte differentiation by HIV protease inhibitors","volume":"84","author":"Zhang","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.017_bib10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.10.017_bib11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib12","article-title":"Comparison of the influence of four classes of HIV antiretrovirals on adipogenic differentiation: the minimal effect of raltegravir and atazanavir","author":"Minami","year":"2010","journal-title":"Journal of Infection and Chemotherapy"},{"key":"10.1016\/j.beem.2010.10.017_bib13","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.1073\/pnas.0704212104","article-title":"HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells","volume":"104","author":"Coffinier","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.beem.2010.10.017_bib14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1042\/BST0380292","article-title":"HIV protease inhibitors inhibit FACE1\/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?","volume":"38","author":"Goulbourne","year":"2010","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.beem.2010.10.017_bib15","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/00002030-200311210-00005","article-title":"Some HIV protease inhibitors alter lamin A\/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation","volume":"17","author":"Caron","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.10.017_bib16","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","article-title":"Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia","volume":"12","author":"Agarwal","year":"2003","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.beem.2010.10.017_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.mol.0000217898.52197.18","article-title":"Lipodystrophy: lessons in lipid and energy metabolism","volume":"17","author":"Simha","year":"2006","journal-title":"Current Opinion in Lipidology"},{"key":"10.1016\/j.beem.2010.10.017_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ecl.2004.03.003","article-title":"Lipodystrophies: rare disorders causing metabolic syndrome","volume":"33","author":"Garg","year":"2004","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2010.10.017_bib19","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.10.017_bib20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4158\/EP09155.RA","article-title":"Rationale for leptin-replacement therapy for severe lipodystrophy","volume":"16","author":"Oral","year":"2010","journal-title":"Endocrine Practice"},{"key":"10.1016\/j.beem.2010.10.017_bib21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/jc.2008-1588","article-title":"The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia","volume":"94","author":"Mulligan","year":"2009","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.017_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2010.10.017_bib23","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1152\/japplphysiol.00845.2002","article-title":"Preferential loss of omental-mesenteric fat during growth hormone therapy of HIV-associated lipodystrophy","volume":"94","author":"He","year":"2003","journal-title":"Journal of Applied Physiology"},{"key":"10.1016\/j.beem.2010.10.017_bib24","doi-asserted-by":"crossref","first-page":"20251","DOI":"10.1074\/jbc.C000228200","article-title":"The mechanism of insulin resistance caused by HIV protease inhibitor therapy","volume":"275","author":"Murata","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.beem.2010.10.017_bib25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","article-title":"Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations","volume":"16","author":"Murata","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.10.017_bib26","doi-asserted-by":"crossref","first-page":"55147","DOI":"10.1074\/jbc.M410826200","article-title":"A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity","volume":"279","author":"Hertel","year":"2004","journal-title":"Journal of Biological Chemistry."},{"key":"10.1016\/j.beem.2010.10.017_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/01.qai.0000245883.66509.b4","article-title":"Tipranavir without ritonavir does not acutely induce peripheral insulin resistance in a rodent model","volume":"43","author":"Hruz","year":"2006","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.10.017_bib28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.qai.0000176654.97392.c7","article-title":"Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal","volume":"40","author":"Yan","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.10.017_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002030-200301030-00005","article-title":"Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors","volume":"17","author":"Ben-Romano","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.10.017_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-2003-44709","article-title":"Therapeutic dose of HIV-1 protease inhibitor saquinavir does not permanently influence early insulin signaling","volume":"111","author":"Algenstaedt","year":"2003","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-004-1408-5","article-title":"Nelfinavir-induced insulin resistance is associated with impaired plasma membrane recruitment of the PI 3-kinase effectors Akt\/PKB and PKC-zeta","volume":"47","author":"Ben-Romano","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2010.10.017_bib32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/135965350601100812","article-title":"Nelfinavir induces adipocyte insulin resistance through the induction of oxidative stress: differential protective effect of antioxidant agents","volume":"11","author":"Ben-Romano","year":"2006","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.beem.2010.10.017_bib33","doi-asserted-by":"crossref","first-page":"E558","DOI":"10.1152\/ajpendo.00167.2007","article-title":"HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus","volume":"294","author":"Carper","year":"2008","journal-title":"American Journal of Physiology - Endocrinology And Metabolism"},{"key":"10.1016\/j.beem.2010.10.017_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2007.11.051","article-title":"TNF-alpha and adipocyte biology","volume":"582","author":"Cawthorn","year":"2008","journal-title":"FEBS Letters"},{"key":"10.1016\/j.beem.2010.10.017_bib35","doi-asserted-by":"crossref","DOI":"10.2337\/dc10-0633","article-title":"Association between systemic inflammation and incident diabetes mellitus in HIV-infected patients after initiation of antiretroviral therapy","author":"Brown","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.10.017_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","article-title":"Inflammatory mechanisms in the regulation of insulin resistance","volume":"14","author":"Tilg","year":"2008","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.beem.2010.10.017_bib37","doi-asserted-by":"crossref","first-page":"G1120","DOI":"10.1152\/ajpgi.00407.2007","article-title":"Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling","volume":"294","author":"Qin","year":"2008","journal-title":"American Journal of Physiology - Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.beem.2010.10.017_bib38","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","article-title":"Endoplasmic reticulum stress and the inflammatory basis of metabolic disease","volume":"140","author":"Hotamisligil","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.beem.2010.10.017_bib39","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1124\/mol.104.010165","article-title":"Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors","volume":"67","author":"Parker","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.beem.2010.10.017_bib40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jac\/dkp316","article-title":"Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?","volume":"64","author":"Maagaard","year":"2009","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.beem.2010.10.017_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mito.2004.05.008","article-title":"Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies","volume":"4","author":"McComsey","year":"2004","journal-title":"Mitochondrion"},{"key":"10.1016\/j.beem.2010.10.017_bib42","article-title":"Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation","author":"Feeney Eoin","year":"2010","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.beem.2010.10.017_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.pathol.2.010506.091859","article-title":"Endocrine functions of adipose tissue","volume":"2","author":"Waki","year":"2007","journal-title":"Annual Review of Pathology"},{"key":"10.1016\/j.beem.2010.10.017_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jinf.2010.06.002","article-title":"The HIV-1\/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications","volume":"61","author":"Tsiodras","year":"2010","journal-title":"Journal of Infection"},{"key":"10.1016\/j.beem.2010.10.017_bib45","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1210\/jc.2007-1155","article-title":"Relationship of fat distribution with adipokines in human immunodeficiency virus infection","volume":"93","author":"Kosmiski","year":"2008","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.017_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/135965350501000202","article-title":"Altered adipokine response in murine 3T3-F442A adipocytes treated with protease inhibitors and nucleoside reverse transcriptase inhibitors","volume":"10","author":"Jones","year":"2005","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.beem.2010.10.017_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","article-title":"Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages","volume":"12","author":"Lagathu","year":"2007","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.beem.2010.10.017_bib48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.qai.0000187443.30838.3e","article-title":"Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens","volume":"40","author":"Jones","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.10.017_bib49","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2337\/diabetes.50.6.1397","article-title":"The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle","volume":"50","author":"Nolte","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib50","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.beem.2010.10.017_bib51","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1172\/JCI200215626","article-title":"Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy","volume":"110","author":"Behrens","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.beem.2010.10.017_bib52","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.51.4.937","article-title":"Indinavir induces acute and reversible peripheral insulin resistance in rats","volume":"51","author":"Hruz","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib53","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/01.aids.0000244200.11006.55","article-title":"Effects of atazanavir\/ritonavir and lopinavir\/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically","volume":"20","author":"Noor","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.10.017_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.qai.0000143599.64234.15","article-title":"Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine","volume":"38","author":"Shlay","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.10.017_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/QAD.0b013e3282f33557","article-title":"Zidovudine\/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy","volume":"22","author":"Blumer","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.10.017_bib56","doi-asserted-by":"crossref","first-page":"E1666","DOI":"10.1152\/ajpendo.00550.2006","article-title":"Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults","volume":"292","author":"Fleischman","year":"2007","journal-title":"American Journal of Physiology - Endocrinology And Metabolism"},{"key":"10.1016\/j.beem.2010.10.017_bib57","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib58","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.2337\/diabetes.51.11.3163","article-title":"Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy","volume":"51","author":"Gan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib59","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1152\/ajpendo.00391.2001","article-title":"Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy","volume":"284","author":"Luzi","year":"2003","journal-title":"American Journal of Physiology - Endocrinology And Metabolism"},{"key":"10.1016\/j.beem.2010.10.017_bib60","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbalip.2010.01.007","article-title":"HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters","volume":"1801","author":"Richmond","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.beem.2010.10.017_bib61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbalip.2009.10.006","article-title":"Lipid homeostasis, lipotoxicity and the metabolic syndrome","volume":"1801","author":"Unger","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.beem.2010.10.017_bib62","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/me.2003-0383","article-title":"Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes","volume":"18","author":"Gao","year":"2004","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.beem.2010.10.017_bib63","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.2337\/diabetes.54.12.3474","article-title":"Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy","volume":"54","author":"Haugaard","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib64","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","article-title":"Adipokines and insulin resistance","volume":"14","author":"Rabe","year":"2008","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.beem.2010.10.017_bib65","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/505974","article-title":"Single-dose lopinavir-ritonavir acutely inhibits insulin-mediated glucose disposal in healthy volunteers","volume":"43","author":"Lee","year":"2006","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.beem.2010.10.017_bib66","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00126334-200405010-00017","article-title":"HIV protease inhibitors increase adiponectin levels in HIV-Negative men","volume":"36","author":"Lee","year":"2004","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.10.017_bib67","doi-asserted-by":"crossref","first-page":"918","DOI":"10.2337\/diabetes.52.4.918","article-title":"Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens","volume":"52","author":"Woerle","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00126334-200106010-00006","article-title":"Prospective evaluation of the effect of initiating indinavir-based therapy on insulin sensitivity and B-cell function in HIV-infected patients","volume":"27","author":"Dube","year":"2001","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.beem.2010.10.017_bib69","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/diabetes.52.7.1695","article-title":"HIV protease inhibitors acutely impair glucose-stimulated insulin release","volume":"52","author":"Koster","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2337\/diab.45.2.223","article-title":"Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm","volume":"45","author":"Matschinsky","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.105.090589","article-title":"HIV protease inhibitors: suppression of insulin secretion by inhibition of voltage-dependent K+ currents and anion currents","volume":"316","author":"Neye","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.beem.2010.10.017_bib72","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1677\/joe.1.05620","article-title":"Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells","volume":"183","author":"Schutt","year":"2004","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.beem.2010.10.017_bib73","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3181\/0811-RM-317","article-title":"HIV-1 protease inhibitor induced oxidative stress suppresses glucose stimulated insulin release: protection with thymoquinone","volume":"234","author":"Chandra","year":"2009","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"key":"10.1016\/j.beem.2010.10.017_bib74","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1152\/ajpendo.90445.2008","article-title":"Protease inhibitors used in the treatment of HIV+ induce beta-cell apoptosis via the mitochondrial pathway and compromise insulin secretion","volume":"296","author":"Zhang","year":"2009","journal-title":"American Journal of Physiology - Endocrinology And Metabolism"},{"key":"10.1016\/j.beem.2010.10.017_bib75","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1097\/00002030-200111090-00004","article-title":"Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways","volume":"15","author":"van der Valk","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.10.017_bib76","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1097\/00002030-200409030-00017","article-title":"Indinavir increases glucose production in healthy HIV-negative men","volume":"18","author":"Schwarz","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.beem.2010.10.017_bib77","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s001250051505","article-title":"The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells","volume":"43","author":"Schutt","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.beem.2010.10.017_bib78","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.2337\/diabetes.49.10.1643","article-title":"Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice","volume":"49","author":"Burcelin","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2010.10.017_bib79","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ecl.2008.09.001","article-title":"Hypothalamic control of hepatic glucose production and its potential role in insulin resistance","volume":"37","author":"Buettner","year":"2008","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2010.10.017_bib80","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/(SICI)1096-9861(19981005)399:4<492::AID-CNE4>3.0.CO;2-X","article-title":"Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system","volume":"399","author":"El Messari","year":"1998","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.beem.2010.10.017_bib81","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2174\/157016207781662407","article-title":"Steatohepatitis in HIV-infected subjects: pathogenesis, clinical impact and implications in clinical management","volume":"5","author":"Bongiovanni","year":"2007","journal-title":"Current HIV Research"},{"key":"10.1016\/j.beem.2010.10.017_bib82","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.beem.2010.10.017_bib83","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"Journal of Biological Chemistry."},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2010.10.017_bib84","first-page":"S11","article-title":"Standards of medical care in diabetes\u20132010","volume":"33","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:44:40Z","timestamp":1761497080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X10001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1521690X10001442"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2010.10.017","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms for insulin resistance in treated HIV-infection","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2010.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}